Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Mental health disorders or mental illness affect the person’s mood, thinking, and behavior. The common mental illness include anxiety, panic attacks, eating disorders, depression, and others. Alprazolam is a tablet which is prescribed for patients suffering from anxiety and panic attacks. The medicine belongs to the benzodiazepines class of drugs that produce a calming effect on the brain and nerves by increasing the production of gamma-Aminobutyric acid (GABA) neurotransmitter.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/4311
Global Alprazolam Tablets Market – Dynamics
The increasing prevalence of anxiety among the world population is expected to drive growth of the global alprazolam tablets markets during the forecast period. For instance, according to the statistics published on 15th June 2020, the Center for Disease Control and Prevention, (CDC), reported that, globally, 7.1% of children in the age group of 3-17 years, or around 4.4 million children, have been diagnosed with anxiety. Furthermore, according to World Health Organization, (WHO), in 2018, around 264 million adults across the globe suffered from anxiety. Out of these, 63% were females and 37% were males.
Moreover, campaigns launched by regulatory authorities are expected to drive sales of original drugs rather than illegal copies of drug, and thereby boost growth of the global alprazolam tablets market. For instance, on 4th August 2020, the U.S. Drug Enforcement Administration (DEA), launched a campaign against the marketing of tablets production kits such as tablet presses, die punches, and chemicals used for illegal drug synthesis. According to the DEA, these kits may be used for making copies of brands marketing alprazolam tablets such as OxyContin or Xanax, by adding fentanyl, heroin, and isotonitazene, as active ingredients instead of alprazolam.
Quick Buy – Alprazolam Tablets Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4311
Global Alprazolam Tablets Market – Regional Insights
North America is expected to dominate the global alprazolam tablet market during the forecast period owing to the increasing prevalence of anxiety among the U.S. population. For instance, according to the Anxiety and Depression Association of America, (ADAA), 2020, currently, 40 million U.S. adults are suffering from anxiety disorders due to the COVID-19 pandemic.
Furthermore, the global alprazolam tablets market is expected to witness significant growth due to health policies for treatment of mental health problems. For instance, in the U.S., eligible residents receive treatment coverage through Medicaid for mental health services and Medicare part A coverage for treatment of depression and anxiety.
Global Alprazolam Tablets Market – Competitive Landscape
Some of the key players operating in the global alprazolam tablets market are Aurobindo Pharma Ltd., Mylan N.V., Par Pharmaceuticals, Pfizer Inc., Taj Pharmaceuticals Ltd., Terrace Pharmaceuticals, Avalanche Pharmaceuticals Pvt. Ltd., Cooper Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., Lupin Limited, and Novartis International AG.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/alprazolam-tablets-market-4311
Global Alprazolam Tablets Market – Taxonomy
On the basis of form, the global alprazolam tablets market is segmented into:
- Immediate Release Tablets
- Extended-Release Capsules
- Orally Disintegrating Tablets
On the basis of application, the global alprazolam tablets market is segmented into:
- Anxiety Disorder
- Panic Attacks
- Others
On the basis of region, the global alprazolam tablets market is segmented into:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837